Engaging private pharmacies to help end TB in India
Int J Tuberc Lung Dis
.
2022 May 1;26(5):457-459.
doi: 10.5588/ijtld.21.0682.
Authors
R Gandhi
1
,
K G Deepak
2
,
G Verma
2
,
S Chaubey
2
,
L Kumar
2
,
J Klinton
3
,
S Raj
2
,
P Jha
1
,
S Vijayan
1
Affiliations
1
PATH, Mumbai office, Mumbai, India.
2
Centre for Health Research and Innovation, Joint Effort for Elimination of TB, New Delhi, India.
3
McGill International TB Center, TB PPM Learning Network, Montreal, QC, Canada.
PMID:
35505482
PMCID:
PMC9067430
DOI:
10.5588/ijtld.21.0682
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Antitubercular Agents / therapeutic use
Humans
India
Pharmacies*
Tuberculosis* / drug therapy
Tuberculosis* / prevention & control
Substances
Antitubercular Agents